dostęp otwarty

Tom 20, Nr 3 (2016)
ORIGINAL PAPERS
Opublikowany online: 2016-09-29
Pobierz cytowanie

Study of the role of L-arginine in the diagnosis of pregnancy-induced hypertension

Agnieszka Grafka, Maciej Łopucki, Katarzyna Karwasik-Kajszczarek, Marzena Stasiak-Kosarzycka, Andrzej Miturski, Grzegorz Dzida
DOI: 10.5603/AH.2016.0017
·
Arterial Hypertension 2016;20(3):113-118.

dostęp otwarty

Tom 20, Nr 3 (2016)
ORIGINAL PAPERS
Opublikowany online: 2016-09-29

Streszczenie

Background Pregnancy-induced hypertension (PIH) is a significant health issue in pregnancy, complicating 7–10% of pregnancies. L-arginine is an important mediator of vasodilation with a potential preventative role in pregnancy-related hypertensive diseases.

Aim of the study The aim of the present study was to assess the differences in plasma L-arginine concentrations in physiological pregnancies and pregnancies complicated with hypertension in the third trimester.

Material and methods Plasma concentration of L-arginine was determined by ion-exchange chromatography in 210 pregnant women (25–41 weeks of gestation). Plasma L-arginine concentration was expressed in μmol/cm3.

Results The mean L-arginine concentration was significantly higher in physiological pregnancy (0.102) than in the PIH group (0.034). The analysis of plasma L-arginine concentration in the subgroups of third trimester showed that L-arginine concentration in the PIH group decreased with increasing stage of pregnancy (25–34 hbd — 0.051; 35–38 hbd — 0.03; 39–41 hbd — 0.02). L-arginine concentration in physiological pregnancies was the same in all subgroups (0.1).

Conclusions L-arginine may have a role in the prevention and treatment of pregnancy-induced hypertension. Further well-designed and adequately powered research is warranted.

Streszczenie

Background Pregnancy-induced hypertension (PIH) is a significant health issue in pregnancy, complicating 7–10% of pregnancies. L-arginine is an important mediator of vasodilation with a potential preventative role in pregnancy-related hypertensive diseases.

Aim of the study The aim of the present study was to assess the differences in plasma L-arginine concentrations in physiological pregnancies and pregnancies complicated with hypertension in the third trimester.

Material and methods Plasma concentration of L-arginine was determined by ion-exchange chromatography in 210 pregnant women (25–41 weeks of gestation). Plasma L-arginine concentration was expressed in μmol/cm3.

Results The mean L-arginine concentration was significantly higher in physiological pregnancy (0.102) than in the PIH group (0.034). The analysis of plasma L-arginine concentration in the subgroups of third trimester showed that L-arginine concentration in the PIH group decreased with increasing stage of pregnancy (25–34 hbd — 0.051; 35–38 hbd — 0.03; 39–41 hbd — 0.02). L-arginine concentration in physiological pregnancies was the same in all subgroups (0.1).

Conclusions L-arginine may have a role in the prevention and treatment of pregnancy-induced hypertension. Further well-designed and adequately powered research is warranted.

Pobierz cytowanie

Słowa kluczowe

L-arginine, pregnant women, hypertension, blood plasma

Informacje o artykule
Tytuł

Study of the role of L-arginine in the diagnosis of pregnancy-induced hypertension

Czasopismo

Arterial Hypertension

Numer

Tom 20, Nr 3 (2016)

Strony

113-118

Data publikacji on-line

2016-09-29

DOI

10.5603/AH.2016.0017

Rekord bibliograficzny

Arterial Hypertension 2016;20(3):113-118.

Słowa kluczowe

L-arginine
pregnant women
hypertension
blood plasma

Autorzy

Agnieszka Grafka
Maciej Łopucki
Katarzyna Karwasik-Kajszczarek
Marzena Stasiak-Kosarzycka
Andrzej Miturski
Grzegorz Dzida

Ważne: serwis https://journals.viamedica.pl/ wykorzystuje pliki cookies. Więcej >>

Używamy informacji zapisanych za pomocą plików cookies m.in. w celach statystycznych, dostosowania serwisu do potrzeb użytkownika (np. język interfejsu) i do obsługi logowania użytkowników. W ustawieniach przeglądarki internetowej można zmienić opcje dotyczące cookies. Korzystanie z serwisu bez zmiany ustawień dotyczących cookies oznacza, że będą one zapisane w pamięci komputera. Więcej informacji można znaleźć w naszej Polityce prywatności.

Czym są i do czego służą pliki cookie możesz dowiedzieć się na stronie wszystkoociasteczkach.pl.

Czasopismo Nadciśnienie Tętnicze dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl